Paperpal Prime Logo

Oncology : Impact Factor & More

eISSN: 1423-0232pISSN: 0030-2414

Key Metrics

CiteScore
5.1
H-Index
104
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oncology

Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher KARGER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1948
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oncology

Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
  • 3 Aug 2026
  • Oncology
Practical Guide for Managing Philadelphia-Negative Myeloproliferative Neoplasms in Patients with Organ Dysfunction.
  • 21 Jul 2026
  • Oncology
A Real-World Pharmacovigilance Analysis of HER2 Inhibitor-Induced Cardiovascular Toxicity.
  • 21 Jul 2026
  • Oncology
Fat mass and survival in immunotherapy-treated metastatic renal cell carcinoma patients.
  • 16 Jul 2026
  • Oncology
Unique stroma of higher-grade pancreatic intraepithelial neoplasia: Fibroblastic cluster formation and CD36-downregulation.
  • 14 Jul 2026
  • Oncology
Emergency Department Visits After Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity.
  • 10 Jul 2026
  • Oncology
Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
  • 3 Aug 2026
  • Oncology
Practical Guide for Managing Philadelphia-Negative Myeloproliferative Neoplasms in Patients with Organ Dysfunction.
  • 21 Jul 2026
  • Oncology
A Real-World Pharmacovigilance Analysis of HER2 Inhibitor-Induced Cardiovascular Toxicity.
  • 21 Jul 2026
  • Oncology
Fat mass and survival in immunotherapy-treated metastatic renal cell carcinoma patients.
  • 16 Jul 2026
  • Oncology
Unique stroma of higher-grade pancreatic intraepithelial neoplasia: Fibroblastic cluster formation and CD36-downregulation.
  • 14 Jul 2026
  • Oncology
Emergency Department Visits After Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity.
  • 10 Jul 2026
  • Oncology

FAQs on Oncology